| Symbol |
Name |
|
AAMP
|
angio-associated, migratory cell protein
|
|
AATF
|
apoptosis antagonizing transcription factor
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC10
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 10
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABCC5
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 5
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABI1
|
abl-interactor 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ACAT1
|
acetyl-CoA acetyltransferase 1
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACKR2
|
atypical chemokine receptor 2
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACKR4
|
atypical chemokine receptor 4
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ACPP
|
acid phosphatase, prostate
|
|
ACSL4
|
acyl-CoA synthetase long-chain family member 4
|
|
ACSM1
|
acyl-CoA synthetase medium-chain family member 1
|
|
ACSS2
|
acyl-CoA synthetase short-chain family member 2
|
|
ACTB
|
actin, beta
|
|
ACTN4
|
actinin, alpha 4
|
|
ACVR1C
|
activin A receptor, type IC
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM22
|
ADAM metallopeptidase domain 22
|
|
ADAM28
|
ADAM metallopeptidase domain 28
|
|
ADAM8
|
ADAM metallopeptidase domain 8
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
ADAMTS15
|
ADAM metallopeptidase with thrombospondin type 1 motif, 15
|
|
ADAMTS8
|
ADAM metallopeptidase with thrombospondin type 1 motif, 8
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
ADGRE2
|
adhesion G protein-coupled receptor E2
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
ADGRF5
|
adhesion G protein-coupled receptor F5
|
|
ADGRL3
|
adhesion G protein-coupled receptor L3
|
|
ADH1A
|
alcohol dehydrogenase 1A (class I), alpha polypeptide
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AFAP1
|
actin filament associated protein 1
|
|
AFF3
|
AF4/FMR2 family, member 3
|
|
AGBL2
|
ATP/GTP binding protein-like 2
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGK
|
acylglycerol kinase
|
|
AGO1
|
argonaute RISC catalytic component 1
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGR2
|
anterior gradient 2
|
|
AGR3
|
anterior gradient 3
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKAP4
|
A kinase (PRKA) anchor protein 4
|
|
AKAP9
|
A kinase (PRKA) anchor protein 9
|
|
AKIP1
|
A kinase (PRKA) interacting protein 1
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1
|
|
AKR1C2
|
aldo-keto reductase family 1, member C2
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALX4
|
ALX homeobox 4
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMH
|
anti-Mullerian hormone
|
|
AMOT
|
angiomotin
|
|
ANAPC1
|
anaphase promoting complex subunit 1
|
|
ANAPC7
|
anaphase promoting complex subunit 7
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANKRD11
|
ankyrin repeat domain 11
|
|
ANKRD30A
|
ankyrin repeat domain 30A
|
|
ANLN
|
anillin, actin binding protein
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANTXR1
|
anthrax toxin receptor 1
|
|
ANTXR2
|
anthrax toxin receptor 2
|
|
ANXA1
|
annexin A1
|
|
ANXA13
|
annexin A13
|
|
ANXA2
|
annexin A2
|
|
ANXA3
|
annexin A3
|
|
ANXA6
|
annexin A6
|
|
ANXA7
|
annexin A7
|
|
ANXA8
|
annexin A8
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APLN
|
apelin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3B
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOD
|
apolipoprotein D
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AQP5
|
aquaporin 5
|
|
AR
|
androgen receptor
|
|
ARAP1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
|
|
AREG
|
amphiregulin
|
|
ARF1
|
ADP-ribosylation factor 1
|
|
ARF4
|
ADP-ribosylation factor 4
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARFGEF1
|
ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)
|
|
ARG2
|
arginase 2
|
|
ARGLU1
|
arginine and glutamate rich 1
|
|
ARHGAP35
|
Rho GTPase activating protein 35
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta
|
|
ARHGEF1
|
Rho guanine nucleotide exchange factor (GEF) 1
|
|
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12
|
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2
|
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like)
|
|
ARID4A
|
AT rich interactive domain 4A (RBP1-like)
|
|
ARID4B
|
AT rich interactive domain 4B (RBP1-like)
|
|
ARL11
|
ADP-ribosylation factor-like 11
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ARRDC3
|
arrestin domain containing 3
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASF1B
|
anti-silencing function 1B histone chaperone
|
|
ASH2L
|
ash2 (absent, small, or homeotic)-like (Drosophila)
|
|
ASRGL1
|
asparaginase like 1
|
|
ASS1
|
argininosuccinate synthase 1
|
|
ATAD2
|
ATPase family, AAA domain containing 2
|
|
ATF1
|
activating transcription factor 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATF3
|
activating transcription factor 3
|
|
ATF4
|
activating transcription factor 4
|
|
ATF5
|
activating transcription factor 5
|
|
ATG10
|
autophagy related 10
|
|
ATG12
|
autophagy related 12
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1B2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
|
ATP2B2
|
ATPase, Ca++ transporting, plasma membrane 2
|
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4
|
|
ATP6V0A1
|
ATPase, H+ transporting, lysosomal V0 subunit a1
|
|
ATP6V0A4
|
ATPase, H+ transporting, lysosomal V0 subunit a4
|
|
ATP6V0C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c
|
|
ATP6V1C1
|
ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1
|
|
ATP6V1G3
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AURKAIP1
|
aurora kinase A interacting protein 1
|
|
AURKB
|
aurora kinase B
|
|
AXIN1
|
axin 1
|
|
AXIN2
|
axin 2
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
B2M
|
beta-2-microglobulin
|
|
B3GALNT2
|
beta-1,3-N-acetylgalactosaminyltransferase 2
|
|
B3GNT8
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8
|
|
B4GALNT1
|
beta-1,4-N-acetyl-galactosaminyl transferase 1
|
|
BABAM1
|
BRISC and BRCA1 A complex member 1
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
BACH1
|
BTB and CNC homology 1, basic leucine zipper transcription factor 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAG4
|
BCL2-associated athanogene 4
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BANP
|
BTG3 associated nuclear protein
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCAP31
|
B-cell receptor-associated protein 31
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCAR3
|
breast cancer anti-estrogen resistance 3
|
|
BCAR4
|
breast cancer anti-estrogen resistance 4 (non-protein coding)
|
|
BCAS2
|
breast carcinoma amplified sequence 2
|
|
BCAS3
|
breast carcinoma amplified sequence 3
|
|
BCAS4
|
breast carcinoma amplified sequence 4
|
|
BCCIP
|
BRCA2 and CDKN1A interacting protein
|
|
BCDIN3D
|
BCDIN3 domain containing
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L12
|
BCL2-like 12 (proline rich)
|
|
BCL2L14
|
BCL2-like 14 (apoptosis facilitator)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCORL1
|
BCL6 corepressor-like 1
|
|
BCYRN1
|
brain cytoplasmic RNA 1
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEX2
|
brain expressed X-linked 2
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BHLHE40
|
basic helix-loop-helix family, member e40
|
|
BHLHE41
|
basic helix-loop-helix family, member e41
|
|
BHMT
|
betaine--homocysteine S-methyltransferase
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIN1
|
bridging integrator 1
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC6
|
baculoviral IAP repeat containing 6
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLCAP
|
bladder cancer associated protein
|
|
BLID
|
BH3-like motif containing, cell death inducer
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP10
|
bone morphogenetic protein 10
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP5
|
bone morphogenetic protein 5
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BP1
|
Blood pressure QTL 1
|
|
BPIFA4P
|
BPI fold containing family A, member 4, pseudogene
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRAP
|
BRCA1 associated protein
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRCA3
|
breast cancer 3
|
|
BRCATA
|
Breast cancer, 11;22 translocation associated
|
|
BRD4
|
bromodomain containing 4
|
|
BRD7
|
bromodomain containing 7
|
|
BRINP1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
BRSK1
|
BR serine/threonine kinase 1
|
|
BRWD3
|
bromodomain and WD repeat domain containing 3
|
|
BSG
|
basigin (Ok blood group)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTC
|
betacellulin
|
|
BTG1
|
B-cell translocation gene 1, anti-proliferative
|
|
BTG2
|
BTG family, member 2
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BTLA
|
B and T lymphocyte associated
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
BUB3
|
BUB3 mitotic checkpoint protein
|
|
C10ORF10
|
chromosome 10 open reading frame 10
|
|
C10ORF90
|
chromosome 10 open reading frame 90
|
|
C11ORF30
|
chromosome 11 open reading frame 30
|
|
C1GALT1
|
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1
|
|
C1GALT1C1
|
C1GALT1-specific chaperone 1
|
|
C1ORF64
|
chromosome 1 open reading frame 64
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
C2ORF40
|
chromosome 2 open reading frame 40
|
|
C3
|
complement component 3
|
|
C6ORF48
|
chromosome 6 open reading frame 48
|
|
C8ORF17
|
chromosome 8 open reading frame 17
|
|
C8ORF4
|
chromosome 8 open reading frame 4
|
|
CA12
|
carbonic anhydrase XII
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CACNA2D3
|
calcium channel, voltage-dependent, alpha 2/delta subunit 3
|
|
CACUL1
|
CDK2-associated, cullin domain 1
|
|
CACYBP
|
calcyclin binding protein
|
|
CADM1
|
cell adhesion molecule 1
|
|
CADM4
|
cell adhesion molecule 4
|
|
CALB2
|
calbindin 2
|
|
CALD1
|
caldesmon 1
|
|
CALML5
|
calmodulin-like 5
|
|
CALR
|
calreticulin
|
|
CAMK1D
|
calcium/calmodulin-dependent protein kinase ID
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta
|
|
CAMLG
|
calcium modulating ligand
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CANX
|
calnexin
|
|
CAP1
|
CAP, adenylate cyclase-associated protein 1 (yeast)
|
|
CAPG
|
capping protein (actin filament), gelsolin-like
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CARM1
|
coactivator-associated arginine methyltransferase 1
|
|
CASC16
|
cancer susceptibility candidate 16 (non-protein coding)
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP14
|
caspase 14, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAST
|
calpastatin
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBLL1
|
Cbl proto-oncogene-like 1, E3 ubiquitin protein ligase
|
|
CBR1
|
carbonyl reductase 1
|
|
CBR3
|
carbonyl reductase 3
|
|
CBS
|
cystathionine-beta-synthase
|
|
CBX2
|
chromobox homolog 2
|
|
CBX5
|
chromobox homolog 5
|
|
CCAR1
|
cell division cycle and apoptosis regulator 1
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCDC170
|
coiled-coil domain containing 170
|
|
CCDC88A
|
coiled-coil domain containing 88A
|
|
CCL14
|
chemokine (C-C motif) ligand 14
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA1
|
cyclin A1
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCNB2
|
cyclin B2
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCND3
|
cyclin D3
|
|
CCNDBP1
|
cyclin D-type binding-protein 1
|
|
CCNE1
|
cyclin E1
|
|
CCNE2
|
cyclin E2
|
|
CCNJ
|
cyclin J
|
|
CCNL1
|
cyclin L1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR4
|
chemokine (C-C motif) receptor 4
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD109
|
CD109 molecule
|
|
CD14
|
CD14 molecule
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD1A
|
CD1a molecule
|
|
CD1D
|
CD1d molecule
|
|
CD200
|
CD200 molecule
|
|
CD209
|
CD209 molecule
|
|
CD24
|
CD24 molecule
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD28
|
CD28 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex)
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD47
|
CD47 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD63
|
CD63 molecule
|
|
CD70
|
CD70 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD80
|
CD80 molecule
|
|
CD82
|
CD82 molecule
|
|
CD9
|
CD9 molecule
|
|
CD99
|
CD99 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC27
|
cell division cycle 27
|
|
CDC42
|
cell division cycle 42
|
|
CDC7
|
cell division cycle 7
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH13
|
cadherin 13
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH23
|
cadherin-related 23
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK10
|
cyclin-dependent kinase 10
|
|
CDK12
|
cyclin-dependent kinase 12
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDK7
|
cyclin-dependent kinase 7
|
|
CDK8
|
cyclin-dependent kinase 8
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKL1
|
cyclin-dependent kinase-like 1 (CDC2-related kinase)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDO1
|
cysteine dioxygenase type 1
|
|
CDR2
|
cerebellar degeneration-related protein 2, 62kDa
|
|
CDT1
|
chromatin licensing and DNA replication factor 1
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM19
|
carcinoembryonic antigen-related cell adhesion molecule 19
|
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CELF2
|
CUGBP, Elav-like family member 2
|
|
CEMIP
|
cell migration inducing protein, hyaluronan binding
|
|
CENPA
|
centromere protein A
|
|
CENPB
|
centromere protein B, 80kDa
|
|
CENPF
|
centromere protein F, 350/400kDa
|
|
CENPH
|
centromere protein H
|
|
CEP55
|
centrosomal protein 55kDa
|
|
CERK
|
ceramide kinase
|
|
CERS2
|
ceramide synthase 2
|
|
CERS6
|
ceramide synthase 6
|
|
CETN1
|
centrin, EF-hand protein, 1
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CGB5
|
chorionic gonadotropin, beta polypeptide 5
|
|
CHAC1
|
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
|
|
CHD5
|
chromodomain helicase DNA binding protein 5
|
|
CHD8
|
chromodomain helicase DNA binding protein 8
|
|
CHDH
|
choline dehydrogenase
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHKA
|
choline kinase alpha
|
|
CHL1
|
cell adhesion molecule L1-like
|
|
CHN2
|
chimerin 2
|
|
CHPT1
|
choline phosphotransferase 1
|
|
CHRAC1
|
chromatin accessibility complex 1
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
|
CHRNA9
|
cholinergic receptor, nicotinic, alpha 9 (neuronal)
|
|
CHST11
|
carbohydrate (chondroitin 4) sulfotransferase 11
|
|
CIAPIN1
|
cytokine induced apoptosis inhibitor 1
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CISD1
|
CDGSH iron sulfur domain 1
|
|
CISD2
|
CDGSH iron sulfur domain 2
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CITED4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
|
|
CIZ1
|
CDKN1A interacting zinc finger protein 1
|
|
CKAP2
|
cytoskeleton associated protein 2
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B
|
|
CKS1BP7
|
CDC28 protein kinase regulatory subunit 1B pseudogene 7
|
|
CKS2
|
CDC28 protein kinase regulatory subunit 2
|
|
CLCA2
|
chloride channel accessory 2
|
|
CLDN1
|
claudin 1
|
|
CLDN16
|
claudin 16
|
|
CLDN2
|
claudin 2
|
|
CLDN3
|
claudin 3
|
|
CLDN4
|
claudin 4
|
|
CLDN5
|
claudin 5
|
|
CLDN6
|
claudin 6
|
|
CLDN7
|
claudin 7
|
|
CLIP1
|
CAP-GLY domain containing linker protein 1
|
|
CLOCK
|
clock circadian regulator
|
|
CLPTM1L
|
CLPTM1-like
|
|
CLSPN
|
claspin
|
|
CLU
|
clusterin
|
|
CMC2
|
C-x(9)-C motif containing 2
|
|
CNKSR1
|
connector enhancer of kinase suppressor of Ras 1
|
|
CNN1
|
calponin 1, basic, smooth muscle
|
|
CNTROB
|
centrobin, centrosomal BRCA2 interacting protein
|
|
COL10A1
|
collagen, type X, alpha 1
|
|
COL11A1
|
collagen, type XI, alpha 1
|
|
COL12A1
|
collagen, type XII, alpha 1
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A2
|
collagen, type IV, alpha 2
|
|
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
COX11
|
COX11 cytochrome c oxidase copper chaperone
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CPD
|
carboxypeptidase D
|
|
CRABP2
|
cellular retinoic acid binding protein 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREB3
|
cAMP responsive element binding protein 3
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRNN
|
cornulin
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRY2
|
cryptochrome circadian clock 2
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYZ
|
crystallin, zeta (quinone reductase)
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSH1
|
chorionic somatomammotropin hormone 1 (placental lactogen)
|
|
CSK
|
c-src tyrosine kinase
|
|
CSMD1
|
CUB and Sushi multiple domains 1
|
|
CSNK1A1
|
casein kinase 1, alpha 1
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CSPP1
|
centrosome and spindle pole associated protein 1
|
|
CST3
|
cystatin C
|
|
CST6
|
cystatin E/M
|
|
CSTA
|
cystatin A (stefin A)
|
|
CT47A11
|
cancer/testis antigen family 47, member A11
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTBP2
|
C-terminal binding protein 2
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTCFL
|
CCCTC-binding factor (zinc finger protein)-like
|
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like
|
|
CTGF
|
connective tissue growth factor
|
|
CTHRC1
|
collagen triple helix repeat containing 1
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTSH
|
cathepsin H
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CTSS
|
cathepsin S
|
|
CTTN
|
cortactin
|
|
CUEDC2
|
CUE domain containing 2
|
|
CUL1
|
cullin 1
|
|
CUL2
|
cullin 2
|
|
CUL3
|
cullin 3
|
|
CUL4A
|
cullin 4A
|
|
CUX1
|
cut-like homeobox 1
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL3
|
chemokine (C-X-C motif) ligand 3
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXXC5
|
CXXC finger protein 5
|
|
CYB5R3
|
cytochrome b5 reductase 3
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2W1
|
cytochrome P450, family 2, subfamily W, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A43
|
cytochrome P450, family 3, subfamily A, polypeptide 43
|
|
CYP4Z1
|
cytochrome P450, family 4, subfamily Z, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DAAM1
|
dishevelled associated activator of morphogenesis 1
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DAB2IP
|
DAB2 interacting protein
|
|
DACH1
|
dachshund family transcription factor 1
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAND5
|
DAN domain family member 5, BMP antagonist
|
|
DAP
|
death-associated protein
|
|
DAP3
|
death associated protein 3
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DBF4
|
DBF4 zinc finger
|
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein
|
|
DCAF6
|
DDB1 and CUL4 associated factor 6
|
|
DCD
|
dermcidin
|
|
DCN
|
decorin
|
|
DDB2
|
damage-specific DNA binding protein 2, 48kDa
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DDR2
|
discoidin domain receptor tyrosine kinase 2
|
|
DDX1
|
DEAD (Asp-Glu-Ala-Asp) box helicase 1
|
|
DDX20
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 20
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DEAF1
|
DEAF1 transcription factor
|
|
DEF6
|
differentially expressed in FDCP 6 homolog (mouse)
|
|
DEK
|
DEK proto-oncogene
|
|
DERL1
|
derlin 1
|
|
DFFA
|
DNA fragmentation factor, 45kDa, alpha polypeptide
|
|
DFNA5
|
deafness, autosomal dominant 5
|
|
DGCR8
|
DGCR8 microprocessor complex subunit
|
|
DHFR
|
dihydrofolate reductase
|
|
DHRS2
|
dehydrogenase/reductase (SDR family) member 2
|
|
DHX9
|
DEAH (Asp-Glu-Ala-His) box helicase 9
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIO1
|
deiodinase, iodothyronine, type I
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DKK4
|
dickkopf WNT signaling pathway inhibitor 4
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLEC1
|
deleted in lung and esophageal cancer 1
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DLX2
|
distal-less homeobox 2
|
|
DLX4
|
distal-less homeobox 4
|
|
DLX5
|
distal-less homeobox 5
|
|
DLX6
|
distal-less homeobox 6
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DMP1
|
dentin matrix acidic phosphoprotein 1
|
|
DMTF1
|
cyclin D binding myb-like transcription factor 1
|
|
DNAJA3
|
DnaJ (Hsp40) homolog, subfamily A, member 3
|
|
DNAJB6
|
DnaJ (Hsp40) homolog, subfamily B, member 6
|
|
DNAJC13
|
DnaJ (Hsp40) homolog, subfamily C, member 13
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOCK1
|
dedicator of cytokinesis 1
|
|
DOK2
|
docking protein 2, 56kDa
|
|
DOK7
|
docking protein 7
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPP8
|
dipeptidyl-peptidase 8
|
|
DPP9
|
dipeptidyl-peptidase 9
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRG1
|
developmentally regulated GTP binding protein 1
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DSC3
|
desmocollin 3
|
|
DTL
|
denticleless E3 ubiquitin protein ligase homolog (Drosophila)
|
|
DUOX2
|
dual oxidase 2
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP22
|
dual specificity phosphatase 22
|
|
DUSP5
|
dual specificity phosphatase 5
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DVL1
|
dishevelled segment polarity protein 1
|
|
DVL2
|
dishevelled segment polarity protein 2
|
|
DYNLL1
|
dynein, light chain, LC8-type 1
|
|
DYNLRB1
|
dynein, light chain, roadblock-type 1
|
|
DYRK2
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2
|
|
DYX1C1
|
dyslexia susceptibility 1 candidate 1
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F2
|
E2F transcription factor 2
|
|
E2F3
|
E2F transcription factor 3
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
ECD
|
ecdysoneless homolog (Drosophila)
|
|
ECHDC1
|
ethylmalonyl-CoA decarboxylase 1
|
|
ECM1
|
extracellular matrix protein 1
|
|
EDN1
|
endothelin 1
|
|
EDN2
|
endothelin 2
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EEF1D
|
eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein)
|
|
EEF2
|
eukaryotic translation elongation factor 2
|
|
EEF2K
|
eukaryotic elongation factor 2 kinase
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
EFNA1
|
ephrin-A1
|
|
EFNB1
|
ephrin-B1
|
|
EGF
|
epidermal growth factor
|
|
EGFL7
|
EGF-like-domain, multiple 7
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
EGR1
|
early growth response 1
|
|
EGR2
|
early growth response 2
|
|
EGR3
|
early growth response 3
|
|
EI24
|
etoposide induced 2.4
|
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF3E
|
eukaryotic translation initiation factor 3, subunit E
|
|
EIF3H
|
eukaryotic translation initiation factor 3, subunit H
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELAC2
|
elaC ribonuclease Z 2
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELF1
|
E74-like factor 1 (ets domain transcription factor)
|
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific )
|
|
ELF5
|
E74-like factor 5 (ets domain transcription factor)
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ELL3
|
elongation factor RNA polymerase II-like 3
|
|
ELMO1
|
engulfment and cell motility 1
|
|
EMILIN2
|
elastin microfibril interfacer 2
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
|
EMP1
|
epithelial membrane protein 1
|
|
EMP3
|
epithelial membrane protein 3
|
|
EMX2
|
empty spiracles homeobox 2
|
|
EN1
|
engrailed homeobox 1
|
|
EN2
|
engrailed homeobox 2
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
ENC1
|
ectodermal-neural cortex 1 (with BTB domain)
|
|
ENDOG
|
endonuclease G
|
|
ENG
|
endoglin
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A)
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA1
|
EPH receptor A1
|
|
EPHA10
|
EPH receptor A10
|
|
EPHA2
|
EPH receptor A2
|
|
EPHA3
|
EPH receptor A3
|
|
EPHA5
|
EPH receptor A5
|
|
EPHA7
|
EPH receptor A7
|
|
EPHB1
|
EPH receptor B1
|
|
EPHB2
|
EPH receptor B2
|
|
EPHB4
|
EPH receptor B4
|
|
EPHB6
|
EPH receptor B6
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
EPSTI1
|
epithelial stromal interaction 1 (breast)
|
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB2IP
|
erbb2 interacting protein
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
EREG
|
epiregulin
|
|
ERLIN2
|
ER lipid raft associated 2
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ERP29
|
endoplasmic reticulum protein 29
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRP1
|
epithelial splicing regulatory protein 1
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ESRRG
|
estrogen-related receptor gamma
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV1
|
ets variant 1
|
|
ETV3
|
ets variant 3
|
|
ETV4
|
ets variant 4
|
|
ETV5
|
ets variant 5
|
|
ETV6
|
ets variant 6
|
|
EVL
|
Enah/Vasp-like
|
|
EXO1
|
exonuclease 1
|
|
EYA2
|
EYA transcriptional coactivator and phosphatase 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F10
|
coagulation factor X
|
|
F11R
|
F11 receptor
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP1
|
fatty acid binding protein 1, liver
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FABP3
|
fatty acid binding protein 3, muscle and heart
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FABP5
|
fatty acid binding protein 5 (psoriasis-associated)
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FADS1
|
fatty acid desaturase 1
|
|
FADS2
|
fatty acid desaturase 2
|
|
FAIM2
|
Fas apoptotic inhibitory molecule 2
|
|
FAM175A
|
family with sequence similarity 175, member A
|
|
FAN1
|
FANCD2/FANCI-associated nuclease 1
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCB
|
Fanconi anemia, complementation group B
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCF
|
Fanconi anemia, complementation group F
|
|
FANCI
|
Fanconi anemia, complementation group I
|
|
FANCL
|
Fanconi anemia, complementation group L
|
|
FANCM
|
Fanconi anemia, complementation group M
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FASTKD2
|
FAST kinase domains 2
|
|
FAT4
|
FAT atypical cadherin 4
|
|
FBL
|
fibrillarin
|
|
FBLIM1
|
filamin binding LIM protein 1
|
|
FBLN1
|
fibulin 1
|
|
FBP1
|
fructose-1,6-bisphosphatase 1
|
|
FBXL17
|
F-box and leucine-rich repeat protein 17
|
|
FBXO31
|
F-box protein 31
|
|
FBXO39
|
F-box protein 39
|
|
FBXO5
|
F-box protein 5
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2C
|
Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FER
|
fer (fps/fes related) tyrosine kinase
|
|
FERMT1
|
fermitin family member 1
|
|
FERMT2
|
fermitin family member 2
|
|
FERMT3
|
fermitin family member 3
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FFAR1
|
free fatty acid receptor 1
|
|
FGA
|
fibrinogen alpha chain
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF19
|
fibroblast growth factor 19
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF4
|
fibroblast growth factor 4
|
|
FGF5
|
fibroblast growth factor 5
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FGFBP1
|
fibroblast growth factor binding protein 1
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FGG
|
fibrinogen gamma chain
|
|
FHIT
|
fragile histidine triad
|
|
FHL2
|
four and a half LIM domains 2
|
|
FHL3
|
four and a half LIM domains 3
|
|
FHOD1
|
formin homology 2 domain containing 1
|
|
FIG4
|
FIG4 phosphoinositide 5-phosphatase
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLNA
|
filamin A, alpha
|
|
FLOT1
|
flotillin 1
|
|
FLOT2
|
flotillin 2
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FLVCR1
|
feline leukemia virus subgroup C cellular receptor 1
|
|
FN1
|
fibronectin 1
|
|
FNBP1L
|
formin binding protein 1-like
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOSL2
|
FOS-like antigen 2
|
|
FOXA1
|
forkhead box A1
|
|
FOXC1
|
forkhead box C1
|
|
FOXC2
|
forkhead box C2
|
|
FOXD1
|
forkhead box D1
|
|
FOXD3
|
forkhead box D3
|
|
FOXF1
|
forkhead box F1
|
|
FOXF2
|
forkhead box F2
|
|
FOXJ2
|
forkhead box J2
|
|
FOXL2
|
forkhead box L2
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP1
|
forkhead box P1
|
|
FOXP3
|
forkhead box P3
|
|
FOXQ1
|
forkhead box Q1
|
|
FPR1
|
formyl peptide receptor 1
|
|
FPR2
|
formyl peptide receptor 2
|
|
FRA6E
|
fragile site, aphidicolin type, common, fra(6)(q26)
|
|
FRK
|
fyn-related Src family tyrosine kinase
|
|
FRZB
|
frizzled-related protein
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FSIP1
|
fibrous sheath interacting protein 1
|
|
FST
|
follistatin
|
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
FTH1
|
ferritin, heavy polypeptide 1
|
|
FTL
|
ferritin, light polypeptide
|
|
FTO
|
fat mass and obesity associated
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FXYD3
|
FXYD domain containing ion transport regulator 3
|
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
|
FZD7
|
frizzled class receptor 7
|
|
FZR1
|
fizzy/cell division cycle 20 related 1 (Drosophila)
|
|
G3BP1
|
GTPase activating protein (SH3 domain) binding protein 1
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GABARAP
|
GABA(A) receptor-associated protein
|
|
GABARAPL1
|
GABA(A) receptor-associated protein like 1
|
|
GABRP
|
gamma-aminobutyric acid (GABA) A receptor, pi
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GALNT14
|
polypeptide N-acetylgalactosaminyltransferase 14
|
|
GALNT6
|
polypeptide N-acetylgalactosaminyltransferase 6
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GAS5
|
growth arrest-specific 5 (non-protein coding)
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GBP2
|
guanylate binding protein 2, interferon-inducible
|
|
GBX2
|
gastrulation brain homeobox 2
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCNT1
|
glucosaminyl (N-acetyl) transferase 1, core 2
|
|
GCNT2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)
|
|
GDE1
|
glycerophosphodiester phosphodiesterase 1
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF2
|
growth differentiation factor 2
|
|
GDF3
|
growth differentiation factor 3
|
|
GDF5
|
growth differentiation factor 5
|
|
GDF9
|
growth differentiation factor 9
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GDPD5
|
glycerophosphodiester phosphodiesterase domain containing 5
|
|
GEN1
|
GEN1 Holliday junction 5' flap endonuclease
|
|
GFRA1
|
GDNF family receptor alpha 1
|
|
GGCT
|
gamma-glutamylcyclotransferase
|
|
GGH
|
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRH
|
growth hormone releasing hormone
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GINS1
|
GINS complex subunit 1 (Psf1 homolog)
|
|
GINS2
|
GINS complex subunit 2 (Psf2 homolog)
|
|
GIPC1
|
GIPC PDZ domain containing family, member 1
|
|
GIT1
|
G protein-coupled receptor kinase interacting ArfGAP 1
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA3
|
gap junction protein, alpha 3, 46kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJC2
|
gap junction protein, gamma 2, 47kDa
|
|
GLCE
|
glucuronic acid epimerase
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLO1
|
glyoxalase I
|
|
GLRX3
|
glutaredoxin 3
|
|
GLS
|
glutaminase
|
|
GLTSCR2
|
glioma tumor suppressor candidate region gene 2
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GMPR2
|
guanosine monophosphate reductase 2
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GNAS
|
GNAS complex locus
|
|
GNB1
|
guanine nucleotide binding protein (G protein), beta polypeptide 1
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar)
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRH2
|
gonadotropin-releasing hormone 2
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GNRHR2
|
gonadotropin-releasing hormone (type 2) receptor 2, pseudogene
|
|
GPAM
|
glycerol-3-phosphate acyltransferase, mitochondrial
|
|
GPATCH2
|
G patch domain containing 2
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPI
|
glucose-6-phosphate isomerase
|
|
GPLD1
|
glycosylphosphatidylinositol specific phospholipase D1
|
|
GPM6B
|
glycoprotein M6B
|
|
GPNMB
|
glycoprotein (transmembrane) nmb
|
|
GPR161
|
G protein-coupled receptor 161
|
|
GPRASP1
|
G protein-coupled receptor associated sorting protein 1
|
|
GPRC5A
|
G protein-coupled receptor, class C, group 5, member A
|
|
GPSM2
|
G-protein signaling modulator 2
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX2
|
glutathione peroxidase 2
|
|
GPX3
|
glutathione peroxidase 3
|
|
GPX4
|
glutathione peroxidase 4
|
|
GPX7
|
glutathione peroxidase 7
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRHL2
|
grainyhead-like 2 (Drosophila)
|
|
GRHL3
|
grainyhead-like 3 (Drosophila)
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GRN
|
granulin
|
|
GRPR
|
gastrin-releasing peptide receptor
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GSPT1
|
G1 to S phase transition 1
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTA2
|
glutathione S-transferase alpha 2
|
|
GSTK1
|
glutathione S-transferase kappa 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM2
|
glutathione S-transferase mu 2 (muscle)
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
GSTO2
|
glutathione S-transferase omega 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GSTZ1
|
glutathione S-transferase zeta 1
|
|
GUCY2F
|
guanylate cyclase 2F, retinal
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
H2AFX
|
H2A histone family, member X
|
|
H2AFZ
|
H2A histone family, member Z
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAP1
|
huntingtin-associated protein 1
|
|
HAPLN3
|
hyaluronan and proteoglycan link protein 3
|
|
HAS2
|
hyaluronan synthase 2
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HBP1
|
HMG-box transcription factor 1
|
|
HCN1
|
hyperpolarization activated cyclic nucleotide gated potassium channel 1
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC4
|
histone deacetylase 4
|
|
HDAC6
|
histone deacetylase 6
|
|
HDAC8
|
histone deacetylase 8
|
|
HDC
|
histidine decarboxylase
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HDLBP
|
high density lipoprotein binding protein
|
|
HERC2
|
HECT and RLD domain containing E3 ubiquitin protein ligase 2
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HES6
|
hes family bHLH transcription factor 6
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HIPK1
|
homeodomain interacting protein kinase 1
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HJURP
|
Holliday junction recognition protein
|
|
HK2
|
hexokinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMGB3
|
high mobility group box 3
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HOTAIR
|
HOX transcript antisense RNA
|
|
HOXA10
|
homeobox A10
|
|
HOXA5
|
homeobox A5
|
|
HOXA9
|
homeobox A9
|
|
HOXB13
|
homeobox B13
|
|
HOXB9
|
homeobox B9
|
|
HOXC11
|
homeobox C11
|
|
HOXC8
|
homeobox C8
|
|
HOXD3
|
homeobox D3
|
|
HP
|
haptoglobin
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HPN
|
hepsin
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRG
|
histidine-rich glycoprotein
|
|
HRH4
|
histamine receptor H4
|
|
HRNR
|
hornerin
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B12
|
hydroxysteroid (17-beta) dehydrogenase 12
|
|
HSD17B14
|
hydroxysteroid (17-beta) dehydrogenase 14
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3
|
|
HSD17B7
|
hydroxysteroid (17-beta) dehydrogenase 7
|
|
HSD17B8
|
hydroxysteroid (17-beta) dehydrogenase 8
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB2
|
heat shock 27kDa protein 2
|
|
HSPB8
|
heat shock 22kDa protein 8
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
HTATIP2
|
HIV-1 Tat interactive protein 2, 30kDa
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTRA3
|
HtrA serine peptidase 3
|
|
HTT
|
huntingtin
|
|
HUNK
|
hormonally up-regulated Neu-associated kinase
|
|
HUS1
|
HUS1 checkpoint homolog (S. pombe)
|
|
HUWE1
|
HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase
|
|
HVCN1
|
hydrogen voltage gated channel 1
|
|
HYAL1
|
hyaluronoglucosaminidase 1
|
|
HYOU1
|
hypoxia up-regulated 1
|
|
IBSP
|
integrin-binding sialoprotein
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM2
|
intercellular adhesion molecule 2
|
|
ICAM5
|
intercellular adhesion molecule 5, telencephalin
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDE
|
insulin-degrading enzyme
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFI6
|
interferon, alpha-inducible protein 6
|
|
IFITM3
|
interferon induced transmembrane protein 3
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFALS
|
insulin-like growth factor binding protein, acid labile subunit
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGFBPL1
|
insulin-like growth factor binding protein-like 1
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHA1
|
immunoglobulin heavy constant alpha 1
|
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker)
|
|
IGHMBP2
|
immunoglobulin mu binding protein 2
|
|
IGK
|
immunoglobulin kappa locus
|
|
IGKC
|
immunoglobulin kappa constant
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL11
|
interleukin 11
|
|
IL11RA
|
interleukin 11 receptor, alpha
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL17A
|
interleukin 17A
|
|
IL17B
|
interleukin 17B
|
|
IL17F
|
interleukin 17F
|
|
IL17RB
|
interleukin 17 receptor B
|
|
IL18
|
interleukin 18
|
|
IL19
|
interleukin 19
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1R2
|
interleukin 1 receptor, type II
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL23R
|
interleukin 23 receptor
|
|
IL24
|
interleukin 24
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL3
|
interleukin 3
|
|
IL32
|
interleukin 32
|
|
IL33R
|
interleukin 33 receptor
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7
|
interleukin 7
|
|
ILK
|
integrin-linked kinase
|
|
ING4
|
inhibitor of growth family, member 4
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
INHBB
|
inhibin, beta B
|
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
INSIG2
|
insulin induced gene 2
|
|
INSL4
|
insulin-like 4 (placenta)
|
|
INSR
|
insulin receptor
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IQSEC1
|
IQ motif and Sec7 domain 1
|
|
IREB2
|
iron-responsive element binding protein 2
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF2BP2
|
interferon regulatory factor 2 binding protein 2
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
IST1
|
increased sodium tolerance 1 homolog (yeast)
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB3BP
|
integrin beta 3 binding protein (beta3-endonexin)
|
|
ITGB4
|
integrin, beta 4
|
|
ITGB5
|
integrin, beta 5
|
|
ITIH5
|
inter-alpha-trypsin inhibitor heavy chain family, member 5
|
|
JADE1
|
jade family PHD finger 1
|
|
JAG1
|
jagged 1
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JMJD6
|
jumonji domain containing 6
|
|
JUN
|
jun proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KAT2A
|
K(lysine) acetyltransferase 2A
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KAT7
|
K(lysine) acetyltransferase 7
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
|
KCNJ6
|
potassium channel, inwardly rectifying subfamily J, member 6
|
|
KCNK5
|
potassium channel, two pore domain subfamily K, member 5
|
|
KCNK9
|
potassium channel, two pore domain subfamily K, member 9
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KCNS1
|
potassium voltage-gated channel, modifier subfamily S, member 1
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM2A
|
lysine (K)-specific demethylase 2A
|
|
KDM2B
|
lysine (K)-specific demethylase 2B
|
|
KDM3B
|
lysine (K)-specific demethylase 3B
|
|
KDM4A
|
lysine (K)-specific demethylase 4A
|
|
KDM4B
|
lysine (K)-specific demethylase 4B
|
|
KDM4C
|
lysine (K)-specific demethylase 4C
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3
|
|
KHSRP
|
KH-type splicing regulatory protein
|
|
KIAA0100
|
KIAA0100
|
|
KIAA0101
|
KIAA0101
|
|
KIAA1524
|
KIAA1524
|
|
KIF14
|
kinesin family member 14
|
|
KIF18A
|
kinesin family member 18A
|
|
KIF1A
|
kinesin family member 1A
|
|
KIF22
|
kinesin family member 22
|
|
KIF26B
|
kinesin family member 26B
|
|
KIF2A
|
kinesin heavy chain member 2A
|
|
KIF2C
|
kinesin family member 2C
|
|
KIFC3
|
kinesin family member C3
|
|
KIN
|
Kin17 DNA and RNA binding protein
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KISS1R
|
KISS1 receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KL
|
klotho
|
|
KLF10
|
Kruppel-like factor 10
|
|
KLF17
|
Kruppel-like factor 17
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLF8
|
Kruppel-like factor 8
|
|
KLHDC7B
|
kelch domain containing 7B
|
|
KLK1
|
kallikrein 1
|
|
KLK10
|
kallikrein-related peptidase 10
|
|
KLK11
|
kallikrein-related peptidase 11
|
|
KLK12
|
kallikrein-related peptidase 12
|
|
KLK13
|
kallikrein-related peptidase 13
|
|
KLK14
|
kallikrein-related peptidase 14
|
|
KLK15
|
kallikrein-related peptidase 15
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK4
|
kallikrein-related peptidase 4
|
|
KLK5
|
kallikrein-related peptidase 5
|
|
KLK6
|
kallikrein-related peptidase 6
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KLLN
|
killin, p53-regulated DNA replication inhibitor
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KMT2E
|
lysine (K)-specific methyltransferase 2E
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT15
|
keratin 15, type I
|
|
KRT16
|
keratin 16, type I
|
|
KRT17
|
keratin 17, type I
|
|
KRT18
|
keratin 18, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT7
|
keratin 7, type II
|
|
KRT75
|
keratin 75, type II
|
|
KRT8
|
keratin 8, type II
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
L3MBTL1
|
l(3)mbt-like 1 (Drosophila)
|
|
L3MBTL4
|
l(3)mbt-like 4 (Drosophila)
|
|
LACRT
|
lacritin
|
|
LAMA3
|
laminin, alpha 3
|
|
LAMA5
|
laminin, alpha 5
|
|
LAMB1
|
laminin, beta 1
|
|
LAMB3
|
laminin, beta 3
|
|
LAMC2
|
laminin, gamma 2
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LAMP3
|
lysosomal-associated membrane protein 3
|
|
LAMTOR2
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2
|
|
LAMTOR3
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3
|
|
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
LARP6
|
La ribonucleoprotein domain family, member 6
|
|
LASP1
|
LIM and SH3 protein 1
|
|
LATS1
|
large tumor suppressor kinase 1
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LBH
|
limb bud and heart development
|
|
LBR
|
lamin B receptor
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LDHB
|
lactate dehydrogenase B
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEFTY1
|
left-right determination factor 1
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LEPR
|
leptin receptor
|
|
LETMD1
|
LETM1 domain containing 1
|
|
LFNG
|
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS3BP
|
lectin, galactoside-binding, soluble, 3 binding protein
|
|
LGALS7
|
lectin, galactoside-binding, soluble, 7
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LGMN
|
legumain
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIF
|
leukemia inhibitory factor
|
|
LIFR
|
leukemia inhibitory factor receptor alpha
|
|
LIG3
|
ligase III, DNA, ATP-dependent
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LIMA1
|
LIM domain and actin binding 1
|
|
LIMD1
|
LIM domains containing 1
|
|
LIMK1
|
LIM domain kinase 1
|
|
LIMK2
|
LIM domain kinase 2
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LINC-PINT
|
long intergenic non-protein coding RNA, p53 induced transcript
|
|
LINC-ROR
|
long intergenic non-protein coding RNA, regulator of reprogramming
|
|
LLGL1
|
lethal giant larvae homolog 1 (Drosophila)
|
|
LLGL2
|
lethal giant larvae homolog 2 (Drosophila)
|
|
LMNA
|
lamin A/C
|
|
LMNB1
|
lamin B1
|
|
LMO4
|
LIM domain only 4
|
|
LMO7
|
LIM domain 7
|
|
LMTK3
|
lemur tyrosine kinase 3
|
|
LNX2
|
ligand of numb-protein X 2
|
|
LOX
|
lysyl oxidase
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LOXL3
|
lysyl oxidase-like 3
|
|
LOXL4
|
lysyl oxidase-like 4
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LPAR2
|
lysophosphatidic acid receptor 2
|
|
LPAR3
|
lysophosphatidic acid receptor 3
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LSM1
|
LSM1, U6 small nuclear RNA associated
|
|
LSM4
|
LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae)
|
|
LSP1
|
lymphocyte-specific protein 1
|
|
LTA
|
lymphotoxin alpha
|
|
LTB4R2
|
leukotriene B4 receptor 2
|
|
LTBP4
|
latent transforming growth factor beta binding protein 4
|
|
LTF
|
lactotransferrin
|
|
LUM
|
lumican
|
|
LY6K
|
lymphocyte antigen 6 complex, locus K
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
LYNX1
|
Ly6/neurotoxin 1
|
|
LYPD3
|
LY6/PLAUR domain containing 3
|
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
|
LZTS1
|
leucine zipper, putative tumor suppressor 1
|
|
MACC1
|
metastasis associated in colon cancer 1
|
|
MACROD1
|
MACRO domain containing 1
|
|
MAD1L1
|
MAD1 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MADD
|
MAP-kinase activating death domain
|
|
MAGEA1
|
melanoma antigen family A1
|
|
MAGEA10
|
melanoma antigen family A10
|
|
MAGEA11
|
melanoma antigen family A11
|
|
MAGEA2
|
melanoma antigen family A2
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAGEA9
|
melanoma antigen family A9
|
|
MAGEC1
|
melanoma antigen family C1
|
|
MAGEC2
|
melanoma antigen family C2
|
|
MAGED1
|
melanoma antigen family D1
|
|
MAL
|
mal, T-cell differentiation protein
|
|
MALAT1
|
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
|
|
MALT1
|
MALT1 paracaspase
|
|
MAP1LC3A
|
microtubule-associated protein 1 light chain 3 alpha
|
|
MAP1LC3B
|
microtubule-associated protein 1 light chain 3 beta
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP2K5
|
mitogen-activated protein kinase kinase 5
|
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K2
|
mitogen-activated protein kinase kinase kinase 2
|
|
MAP3K3
|
mitogen-activated protein kinase kinase kinase 3
|
|
MAP3K4
|
mitogen-activated protein kinase kinase kinase 4
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK12
|
mitogen-activated protein kinase 12
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MARK4
|
MAP/microtubule affinity-regulating kinase 4
|
|
MAST1
|
microtubule associated serine/threonine kinase 1
|
|
MAST2
|
microtubule associated serine/threonine kinase 2
|
|
MATK
|
megakaryocyte-associated tyrosine kinase
|
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor)
|
|
MB
|
myoglobin
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCC
|
mutated in colorectal cancers
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MCPH1
|
microcephalin 1
|
|
MCU
|
mitochondrial calcium uniporter
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED1
|
mediator complex subunit 1
|
|
MED14
|
mediator complex subunit 14
|
|
MED19
|
mediator complex subunit 19
|
|
MED22
|
mediator complex subunit 22
|
|
MED28
|
mediator complex subunit 28
|
|
MEGF9
|
multiple EGF-like-domains 9
|
|
MEIS1
|
Meis homeobox 1
|
|
MELK
|
maternal embryonic leucine zipper kinase
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEST
|
mesoderm specific transcript
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFGE8
|
milk fat globule-EGF factor 8 protein
|
|
MFN2
|
mitofusin 2
|
|
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase)
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIB1
|
mindbomb E3 ubiquitin protein ligase 1
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIEN1
|
migration and invasion enhancer 1
|
|
MIER1
|
mesoderm induction early response 1, transcriptional regulator
|
|
MIER3
|
mesoderm induction early response 1, family member 3
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIIP
|
migration and invasion inhibitory protein
|
|
MINA
|
MYC induced nuclear antigen
|
|
MIR100
|
microRNA 100
|
|
MIR101-1
|
microRNA 101-1
|
|
MIR101-2
|
microRNA 101-2
|
|
MIR106A
|
microRNA 106a
|
|
MIR106B
|
microRNA 106b
|
|
MIR10A
|
microRNA 10a
|
|
MIR10B
|
microRNA 10b
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR124-2
|
microRNA 124-2
|
|
MIR124-3
|
microRNA 124-3
|
|
MIR1258
|
microRNA 1258
|
|
MIR125A
|
microRNA 125a
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR125B2
|
microRNA 125b-2
|
|
MIR126
|
microRNA 126
|
|
MIR127
|
microRNA 127
|
|
MIR128-1
|
microRNA 128-1
|
|
MIR1290
|
microRNA 1290
|
|
MIR132
|
microRNA 132
|
|
MIR133B
|
microRNA 133b
|
|
MIR140
|
microRNA 140
|
|
MIR141
|
microRNA 141
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR146B
|
microRNA 146b
|
|
MIR147A
|
microRNA 147a
|
|
MIR148A
|
microRNA 148a
|
|
MIR148B
|
microRNA 148b
|
|
MIR149
|
microRNA 149
|
|
MIR150
|
microRNA 150
|
|
MIR151A
|
microRNA 151a
|
|
MIR153-1
|
microRNA 153-1
|
|
MIR155
|
microRNA 155
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR17
|
microRNA 17
|
|
MIR181A1
|
microRNA 181a-1
|
|
MIR181A2
|
microRNA 181a-2
|
|
MIR182
|
microRNA 182
|
|
MIR183
|
microRNA 183
|
|
MIR185
|
microRNA 185
|
|
MIR187
|
microRNA 187
|
|
MIR18A
|
microRNA 18a
|
|
MIR18B
|
microRNA 18b
|
|
MIR190A
|
microRNA 190a
|
|
MIR191
|
microRNA 191
|
|
MIR192
|
microRNA 192
|
|
MIR193A
|
microRNA 193a
|
|
MIR193B
|
microRNA 193b
|
|
MIR195
|
microRNA 195
|
|
MIR196A1
|
microRNA 196a-1
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR196B
|
microRNA 196b
|
|
MIR199B
|
microRNA 199b
|
|
MIR19A
|
microRNA 19a
|
|
MIR200A
|
microRNA 200a
|
|
MIR200B
|
microRNA 200b
|
|
MIR200C
|
microRNA 200c
|
|
MIR203A
|
microRNA 203a
|
|
MIR205
|
microRNA 205
|
|
MIR206
|
microRNA 206
|
|
MIR20A
|
microRNA 20a
|
|
MIR20B
|
microRNA 20b
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR214
|
microRNA 214
|
|
MIR218-1
|
microRNA 218-1
|
|
MIR219A1
|
microRNA 219a-1
|
|
MIR22
|
microRNA 22
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR223
|
microRNA 223
|
|
MIR224
|
microRNA 224
|
|
MIR23B
|
microRNA 23b
|
|
MIR24-1
|
microRNA 24-1
|
|
MIR24-2
|
microRNA 24-2
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR26B
|
microRNA 26b
|
|
MIR27A
|
microRNA 27a
|
|
MIR27B
|
microRNA 27b
|
|
MIR28
|
microRNA 28
|
|
MIR296
|
microRNA 296
|
|
MIR298
|
microRNA 298
|
|
MIR29A
|
microRNA 29a
|
|
MIR29C
|
microRNA 29c
|
|
MIR301A
|
microRNA 301a
|
|
MIR302A
|
microRNA 302a
|
|
MIR30A
|
microRNA 30a
|
|
MIR30C1
|
microRNA 30c-1
|
|
MIR31
|
microRNA 31
|
|
MIR3134
|
microRNA 3134
|
|
MIR328
|
microRNA 328
|
|
MIR335
|
microRNA 335
|
|
MIR339
|
microRNA 339
|
|
MIR340
|
microRNA 340
|
|
MIR342
|
microRNA 342
|
|
MIR34A
|
microRNA 34a
|
|
MIR34B
|
microRNA 34b
|
|
MIR34C
|
microRNA 34c
|
|
MIR363
|
microRNA 363
|
|
MIR373
|
microRNA 373
|
|
MIR374A
|
microRNA 374a
|
|
MIR374B
|
microRNA 374b
|
|
MIR375
|
microRNA 375
|
|
MIR376A1
|
microRNA 376a-1
|
|
MIR376C
|
microRNA 376c
|
|
MIR378A
|
microRNA 378a
|
|
MIR379
|
microRNA 379
|
|
MIR409
|
microRNA 409
|
|
MIR423
|
microRNA 423
|
|
MIR424
|
microRNA 424
|
|
MIR425
|
microRNA 425
|
|
MIR429
|
microRNA 429
|
|
MIR450B
|
microRNA 450b
|
|
MIR452
|
microRNA 452
|
|
MIR484
|
microRNA 484
|
|
MIR485
|
microRNA 485
|
|
MIR487A
|
microRNA 487a
|
|
MIR489
|
microRNA 489
|
|
MIR496
|
microRNA 496
|
|
MIR497
|
microRNA 497
|
|
MIR499A
|
microRNA 499a
|
|
MIR502
|
microRNA 502
|
|
MIR503
|
microRNA 503
|
|
MIR510
|
microRNA 510
|
|
MIR515-1
|
microRNA 515-1
|
|
MIR519A1
|
microRNA 519a-1
|
|
MIR519B
|
microRNA 519b
|
|
MIR519C
|
microRNA 519c
|
|
MIR520B
|
microRNA 520b
|
|
MIR520C
|
microRNA 520c
|
|
MIR569
|
microRNA 569
|
|
MIR584
|
microRNA 584
|
|
MIR608
|
microRNA 608
|
|
MIR612
|
microRNA 612
|
|
MIR630
|
microRNA 630
|
|
MIR633
|
microRNA 633
|
|
MIR652
|
microRNA 652
|
|
MIR661
|
microRNA 661
|
|
MIR7-1
|
microRNA 7-1
|
|
MIR874
|
microRNA 874
|
|
MIR93
|
microRNA 93
|
|
MIR96
|
microRNA 96
|
|
MIR98
|
microRNA 98
|
|
MIR99A
|
microRNA 99a
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MIRLET7B
|
microRNA let-7b
|
|
MIRLET7G
|
microRNA let-7g
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MKL2
|
MKL/myocardin-like 2
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLF2
|
myeloid leukemia factor 2
|
|
MLH1
|
mutL homolog 1
|
|
MLLT11
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11
|
|
MLLT4
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4
|
|
MLXIPL
|
MLX interacting protein-like
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP21
|
matrix metallopeptidase 21
|
|
MMP26
|
matrix metallopeptidase 26
|
|
MMP28
|
matrix metallopeptidase 28
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MORF4L1
|
mortality factor 4 like 1
|
|
MPHOSPH8
|
M-phase phosphoprotein 8
|
|
MPO
|
myeloperoxidase
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MRPL41
|
mitochondrial ribosomal protein L41
|
|
MRPS30
|
mitochondrial ribosomal protein S30
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSI1
|
musashi RNA-binding protein 1
|
|
MSLN
|
mesothelin
|
|
MSN
|
moesin
|
|
MSRA
|
methionine sulfoxide reductase A
|
|
MST1
|
macrophage stimulating 1
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MSX1
|
msh homeobox 1
|
|
MSX2
|
msh homeobox 2
|
|
MT2A
|
metallothionein 2A
|
|
MTA1
|
metastasis associated 1
|
|
MTA2
|
metastasis associated 1 family, member 2
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTDH
|
metadherin
|
|
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
|
|
MTHFD2
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTO1
|
mitochondrial tRNA translation optimization 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MTSS1
|
metastasis suppressor 1
|
|
MTUS1
|
microtubule associated tumor suppressor 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MUCL1
|
mucin-like 1
|
|
MUTYH
|
mutY homolog
|
|
MVP
|
major vault protein
|
|
MXI1
|
MAX interactor 1, dimerization protein
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYBBP1A
|
MYB binding protein (P160) 1a
|
|
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
MYL9
|
myosin, light chain 9, regulatory
|
|
MYLK
|
myosin light chain kinase
|
|
MYO10
|
myosin X
|
|
MYOCD
|
myocardin
|
|
MYOF
|
myoferlin
|
|
MZF1
|
myeloid zinc finger 1
|
|
NAA10
|
N(alpha)-acetyltransferase 10, NatA catalytic subunit
|
|
NAIP
|
NLR family, apoptosis inhibitory protein
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NBR1
|
neighbor of BRCA1 gene 1
|
|
NCAM2
|
neural cell adhesion molecule 2
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOA7
|
nuclear receptor coactivator 7
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NCSTN
|
nicastrin
|
|
NDC80
|
NDC80 kinetochore complex component
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDRG2
|
NDRG family member 2
|
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NDUFAF4
|
NADH dehydrogenase (ubiquinone) complex I, assembly factor 4
|
|
NDUFS3
|
NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase)
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NEK2
|
NIMA-related kinase 2
|
|
NEK3
|
NIMA-related kinase 3
|
|
NELFB
|
negative elongation factor complex member B
|
|
NELFCD
|
negative elongation factor complex member C/D
|
|
NES
|
nestin
|
|
NET1
|
neuroepithelial cell transforming 1
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIB
|
nuclear factor I/B
|
|
NFIC
|
nuclear factor I/C (CCAAT-binding transcription factor)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFYA
|
nuclear transcription factor Y, alpha
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NINL
|
ninein-like
|
|
NISCH
|
nischarin
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NME2
|
NME/NM23 nucleoside diphosphate kinase 2
|
|
NMI
|
N-myc (and STAT) interactor
|
|
NNMT
|
nicotinamide N-methyltransferase
|
|
NOB1
|
NIN1/RPN12 binding protein 1 homolog (S. cerevisiae)
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOG
|
noggin
|
|
NOL3
|
nucleolar protein 3 (apoptosis repressor with CARD domain)
|
|
NONO
|
non-POU domain containing, octamer-binding
|
|
NOP16
|
NOP16 nucleolar protein
|
|
NOS1AP
|
nitric oxide synthase 1 (neuronal) adaptor protein
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NOTCH4
|
notch 4
|
|
NOV
|
nephroblastoma overexpressed
|
|
NOX4
|
NADPH oxidase 4
|
|
NPAS2
|
neuronal PAS domain protein 2
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPRL2
|
nitrogen permease regulator-like 2 (S. cerevisiae)
|
|
NPY5R
|
neuropeptide Y receptor Y5
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2E3
|
nuclear receptor subfamily 2, group E, member 3
|
|
NR2F1
|
nuclear receptor subfamily 2, group F, member 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NRARP
|
NOTCH-regulated ankyrin repeat protein
|
|
NRG1
|
neuregulin 1
|
|
NRG2
|
neuregulin 2
|
|
NRG3
|
neuregulin 3
|
|
NRG4
|
neuregulin 4
|
|
NRIP1
|
nuclear receptor interacting protein 1
|
|
NRP1
|
neuropilin 1
|
|
NRP2
|
neuropilin 2
|
|
NRXN3
|
neurexin 3
|
|
NSUN2
|
NOP2/Sun RNA methyltransferase family, member 2
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NTF3
|
neurotrophin 3
|
|
NTF4
|
neurotrophin 4
|
|
NTN1
|
netrin 1
|
|
NTN4
|
netrin 4
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NTS
|
neurotensin
|
|
NTSR1
|
neurotensin receptor 1 (high affinity)
|
|
NUCB2
|
nucleobindin 2
|
|
NUCKS1
|
nuclear casein kinase and cyclin-dependent kinase substrate 1
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
NUDT1
|
nudix (nucleoside diphosphate linked moiety X)-type motif 1
|
|
NUDT2
|
nudix (nucleoside diphosphate linked moiety X)-type motif 2
|
|
NUMA1
|
nuclear mitotic apparatus protein 1
|
|
NUMB
|
numb homolog (Drosophila)
|
|
NUP214
|
nucleoporin 214kDa
|
|
NUPR1
|
nuclear protein, transcriptional regulator, 1
|
|
NUS1
|
nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae)
|
|
OBSCN
|
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
|
|
OCLN
|
occludin
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
OLA1
|
Obg-like ATPase 1
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OPRM1
|
opioid receptor, mu 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORAI3
|
ORAI calcium release-activated calcium modulator 3
|
|
OSGIN1
|
oxidative stress induced growth inhibitor 1
|
|
OSM
|
oncostatin M
|
|
OTP
|
orthopedia homeobox
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
P3H2
|
prolyl 3-hydroxylase 2
|
|
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAGR1
|
PAXIP1 associated glutamate-rich protein 1
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PAOX
|
polyamine oxidase (exo-N4-amino)
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PAPSS1
|
3'-phosphoadenosine 5'-phosphosulfate synthase 1
|
|
PARD3
|
par-3 family cell polarity regulator
|
|
PARD6A
|
par-6 family cell polarity regulator alpha
|
|
PARG
|
poly (ADP-ribose) glycohydrolase
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARVA
|
parvin, alpha
|
|
PARVB
|
parvin, beta
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PAX6
|
paired box 6
|
|
PAX8
|
paired box 8
|
|
PBK
|
PDZ binding kinase
|
|
PBOV1
|
prostate and breast cancer overexpressed 1
|
|
PBRM1
|
polybromo 1
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCBP1
|
poly(rC) binding protein 1
|
|
PCDH7
|
protocadherin 7
|
|
PCGF2
|
polycomb group ring finger 2
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK1
|
proprotein convertase subtilisin/kexin type 1
|
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2
|
|
PCSK6
|
proprotein convertase subtilisin/kexin type 6
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDE9A
|
phosphodiesterase 9A
|
|
PDF
|
peptide deformylase (mitochondrial)
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PDLIM2
|
PDZ and LIM domain 2 (mystique)
|
|
PDLIM4
|
PDZ and LIM domain 4
|
|
PDLIM7
|
PDZ and LIM domain 7 (enigma)
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PDPN
|
podoplanin
|
|
PDZK1
|
PDZ domain containing 1
|
|
PDZK1IP1
|
PDZK1 interacting protein 1
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PEAK1
|
pseudopodium-enriched atypical kinase 1
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEBP4
|
phosphatidylethanolamine-binding protein 4
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PEMT
|
phosphatidylethanolamine N-methyltransferase
|
|
PEPD
|
peptidase D
|
|
PER1
|
period circadian clock 1
|
|
PER2
|
period circadian clock 2
|
|
PER3
|
period circadian clock 3
|
|
PERP
|
PERP, TP53 apoptosis effector
|
|
PES1
|
pescadillo ribosomal biogenesis factor 1
|
|
PFKFB4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
|
|
PFKM
|
phosphofructokinase, muscle
|
|
PFKP
|
phosphofructokinase, platelet
|
|
PFN1
|
profilin 1
|
|
PFN2
|
profilin 2
|
|
PGC
|
progastricsin (pepsinogen C)
|
|
PGK1
|
phosphoglycerate kinase 1
|
|
PGR
|
progesterone receptor
|
|
PGRMC1
|
progesterone receptor membrane component 1
|
|
PHACTR1
|
phosphatase and actin regulator 1
|
|
PHB
|
prohibitin
|
|
PHB2
|
prohibitin 2
|
|
PHF2
|
PHD finger protein 2
|
|
PHGDH
|
phosphoglycerate dehydrogenase
|
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1
|
|
PHRF1
|
PHD and ring finger domains 1
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PIAS1
|
protein inhibitor of activated STAT, 1
|
|
PIAS3
|
protein inhibitor of activated STAT, 3
|
|
PIBF1
|
progesterone immunomodulatory binding factor 1
|
|
PICK1
|
protein interacting with PRKCA 1
|
|
PIF1
|
PIF1 5'-to-3' DNA helicase
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIK3R2
|
phosphoinositide-3-kinase, regulatory subunit 2 (beta)
|
|
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PIP
|
prolactin-induced protein
|
|
PIP4K2A
|
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha
|
|
PIP4K2B
|
phosphatidylinositol-5-phosphate 4-kinase, type II, beta
|
|
PIP5K1A
|
phosphatidylinositol-4-phosphate 5-kinase, type I, alpha
|
|
PIP5K1C
|
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma
|
|
PITPNM3
|
PITPNM family member 3
|
|
PITX2
|
paired-like homeodomain 2
|
|
PIWIL2
|
piwi-like RNA-mediated gene silencing 2
|
|
PKIB
|
protein kinase (cAMP-dependent, catalytic) inhibitor beta
|
|
PKLR
|
pyruvate kinase, liver and RBC
|
|
PKM
|
pyruvate kinase, muscle
|
|
PKP1
|
plakophilin 1
|
|
PKP2
|
plakophilin 2
|
|
PKP3
|
plakophilin 3
|
|
PLA2G10
|
phospholipase A2, group X
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G3
|
phospholipase A2, group III
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAC1
|
placenta-specific 1
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB2
|
phospholipase C, beta 2
|
|
PLCD1
|
phospholipase C, delta 1
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLD2
|
phospholipase D2
|
|
PLEKHG6
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 6
|
|
PLG
|
plasminogen
|
|
PLIN2
|
perilipin 2
|
|
PLK1
|
polo-like kinase 1
|
|
PLK3
|
polo-like kinase 3
|
|
PLK4
|
polo-like kinase 4
|
|
PLTP
|
phospholipid transfer protein
|
|
PLXNA1
|
plexin A1
|
|
PLXNA2
|
plexin A2
|
|
PLXNA3
|
plexin A3
|
|
PLXNB1
|
plexin B1
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1
|
|
PML
|
promyelocytic leukemia
|
|
PMP22
|
peripheral myelin protein 22
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNRC1
|
proline-rich nuclear receptor coactivator 1
|
|
PODXL
|
podocalyxin-like
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLDIP2
|
polymerase (DNA-directed), delta interacting protein 2
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLI
|
polymerase (DNA directed) iota
|
|
POLQ
|
polymerase (DNA directed), theta
|
|
POMP
|
proteasome maturation protein
|
|
PON1
|
paraoxonase 1
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POT1
|
protection of telomeres 1
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
POU3F1
|
POU class 3 homeobox 1
|
|
POU4F2
|
POU class 4 homeobox 2
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
POU5F1B
|
POU class 5 homeobox 1B
|
|
PPAPDC1B
|
phosphatidic acid phosphatase type 2 domain containing 1B
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
|
PPFIA1
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPIB
|
peptidylprolyl isomerase B (cyclophilin B)
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPM1F
|
protein phosphatase, Mg2+/Mn2+ dependent, 1F
|
|
PPP1R13B
|
protein phosphatase 1, regulatory subunit 13B
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
PPP5C
|
protein phosphatase 5, catalytic subunit
|
|
PPP6C
|
protein phosphatase 6, catalytic subunit
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRC1
|
protein regulator of cytokinesis 1
|
|
PRCP
|
prolylcarboxypeptidase (angiotensinase C)
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM14
|
PR domain containing 14
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRDX5
|
peroxiredoxin 5
|
|
PRDX6
|
peroxiredoxin 6
|
|
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
|
|
PREX2
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2
|
|
PRG4
|
proteoglycan 4
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
PRKAG1
|
protein kinase, AMP-activated, gamma 1 non-catalytic subunit
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCDBP
|
protein kinase C, delta binding protein
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKD2
|
protein kinase D2
|
|
PRKD3
|
protein kinase D3
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRKG2
|
protein kinase, cGMP-dependent, type II
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PRMT2
|
protein arginine methyltransferase 2
|
|
PRMT6
|
protein arginine methyltransferase 6
|
|
PRMT7
|
protein arginine methyltransferase 7
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROM1
|
prominin 1
|
|
PROX1
|
prospero homeobox 1
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PRPF4B
|
pre-mRNA processing factor 4B
|
|
PRR5
|
proline rich 5 (renal)
|
|
PRRC2A
|
proline-rich coiled-coil 2A
|
|
PRSS23
|
protease, serine, 23
|
|
PRSS3
|
protease, serine, 3
|
|
PRSS3P2
|
protease, serine, 3 pseudogene 2
|
|
PRSS50
|
protease, serine, 50
|
|
PRSS8
|
protease, serine, 8
|
|
PRUNE
|
prune exopolyphosphatase
|
|
PSAP
|
prosaposin
|
|
PSCA
|
prostate stem cell antigen
|
|
PSD4
|
pleckstrin and Sec7 domain containing 4
|
|
PSEN2
|
presenilin 2
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PSMB7
|
proteasome (prosome, macropain) subunit, beta type, 7
|
|
PSMD10
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
|
|
PSMD9
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
|
|
PSME3
|
proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)
|
|
PSPC1
|
paraspeckle component 1
|
|
PSPHP1
|
phosphoserine phosphatase pseudogene 1
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGES3
|
prostaglandin E synthase 3 (cytosolic)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTK6
|
protein tyrosine kinase 6
|
|
PTK7
|
protein tyrosine kinase 7 (inactive)
|
|
PTN
|
pleiotrophin
|
|
PTOV1
|
prostate tumor overexpressed 1
|
|
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1
|
|
PTP4A2
|
protein tyrosine phosphatase type IVA, member 2
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN23
|
protein tyrosine phosphatase, non-receptor type 23
|
|
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPN9
|
protein tyrosine phosphatase, non-receptor type 9
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
PTPRB
|
protein tyrosine phosphatase, receptor type, B
|
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E
|
|
PTPRG
|
protein tyrosine phosphatase, receptor type, G
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PTPRK
|
protein tyrosine phosphatase, receptor type, K
|
|
PTPRM
|
protein tyrosine phosphatase, receptor type, M
|
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O
|
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1
|
|
PTRF
|
polymerase I and transcript release factor
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PTTG1IP
|
pituitary tumor-transforming 1 interacting protein
|
|
PTX3
|
pentraxin 3, long
|
|
PUM1
|
pumilio RNA-binding family member 1
|
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C)
|
|
PVRL3
|
poliovirus receptor-related 3
|
|
PVRL4
|
poliovirus receptor-related 4
|
|
PVT1
|
Pvt1 oncogene (non-protein coding)
|
|
PXN
|
paxillin
|
|
PYCARD
|
PYD and CARD domain containing
|
|
PYGO2
|
pygopus family PHD finger 2
|
|
PYHIN1
|
pyrin and HIN domain family, member 1
|
|
QKI
|
QKI, KH domain containing, RNA binding
|
|
QSOX1
|
quiescin Q6 sulfhydryl oxidase 1
|
|
RAB11FIP1
|
RAB11 family interacting protein 1 (class I)
|
|
RAB11FIP3
|
RAB11 family interacting protein 3 (class II)
|
|
RAB22A
|
RAB22A, member RAS oncogene family
|
|
RAB25
|
RAB25, member RAS oncogene family
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAB27B
|
RAB27B, member RAS oncogene family
|
|
RAB31
|
RAB31, member RAS oncogene family
|
|
RAB40B
|
RAB40B, member RAS oncogene family
|
|
RAB5A
|
RAB5A, member RAS oncogene family
|
|
RAB6C
|
RAB6C, member RAS oncogene family
|
|
RABEP1
|
rabaptin, RAB GTPase binding effector protein 1
|
|
RABEP2
|
rabaptin, RAB GTPase binding effector protein 2
|
|
RABGEF1
|
RAB guanine nucleotide exchange factor (GEF) 1
|
|
RABL6
|
RAB, member RAS oncogene family-like 6
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
|
|
RACGAP1
|
Rac GTPase activating protein 1
|
|
RAD17
|
RAD17 homolog (S. pombe)
|
|
RAD21
|
RAD21 homolog (S. pombe)
|
|
RAD23B
|
RAD23 homolog B (S. cerevisiae)
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RAD51B
|
RAD51 paralog B
|
|
RAD51C
|
RAD51 paralog C
|
|
RAD51D
|
RAD51 paralog D
|
|
RAD52
|
RAD52 homolog (S. cerevisiae)
|
|
RAD54B
|
RAD54 homolog B (S. cerevisiae)
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RADIL
|
Ras association and DIL domains
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAG2
|
recombination activating gene 2
|
|
RAMP3
|
receptor (G protein-coupled) activity modifying protein 3
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP1GDS1
|
RAP1, GTP-GDP dissociation stimulator 1
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1
|
|
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated)
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2
|
|
RB1
|
retinoblastoma 1
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RBBP4
|
retinoblastoma binding protein 4
|
|
RBBP7
|
retinoblastoma binding protein 7
|
|
RBBP8
|
retinoblastoma binding protein 8
|
|
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1
|
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2
|
|
RBL1
|
retinoblastoma-like 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBM10
|
RNA binding motif protein 10
|
|
RBM3
|
RNA binding motif (RNP1, RRM) protein 3
|
|
RBM38
|
RNA binding motif protein 38
|
|
RBM39
|
RNA binding motif protein 39
|
|
RBM4
|
RNA binding motif protein 4
|
|
RBM5
|
RNA binding motif protein 5
|
|
RBMX
|
RNA binding motif protein, X-linked
|
|
RBP2
|
retinol binding protein 2, cellular
|
|
RCHY1
|
ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
RECQL4
|
RecQ protein-like 4
|
|
RECQL5
|
RecQ protein-like 5
|
|
REG1A
|
regenerating islet-derived 1 alpha
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RELN
|
reelin
|
|
REPS1
|
RALBP1 associated Eps domain containing 1
|
|
REPS2
|
RALBP1 associated Eps domain containing 2
|
|
RERG
|
RAS-like, estrogen-regulated, growth inhibitor
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
RFC3
|
replication factor C (activator 1) 3, 38kDa
|
|
RFTN1
|
raftlin, lipid raft linker 1
|
|
RFWD2
|
ring finger and WD repeat domain 2, E3 ubiquitin protein ligase
|
|
RFX1
|
regulatory factor X, 1 (influences HLA class II expression)
|
|
RGMA
|
repulsive guidance molecule family member a
|
|
RGMB
|
repulsive guidance molecule family member b
|
|
RGN
|
regucalcin
|
|
RGS16
|
regulator of G-protein signaling 16
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RGS6
|
regulator of G-protein signaling 6
|
|
RGS8
|
regulator of G-protein signaling 8
|
|
RGSL1
|
regulator of G-protein signaling like 1
|
|
RHBDD2
|
rhomboid domain containing 2
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHNO1
|
RAD9-HUS1-RAD1 interacting nuclear orphan 1
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOBTB2
|
Rho-related BTB domain containing 2
|
|
RHOC
|
ras homolog family member C
|
|
RHOD
|
ras homolog family member D
|
|
RHOG
|
ras homolog family member G
|
|
RHOU
|
ras homolog family member U
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RIF1
|
replication timing regulatory factor 1
|
|
RIN1
|
Ras and Rab interactor 1
|
|
RINT1
|
RAD50 interactor 1
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RMI1
|
RecQ mediated genome instability 1
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNF11
|
ring finger protein 11
|
|
RNF115
|
ring finger protein 115
|
|
RNF146
|
ring finger protein 146
|
|
RNF168
|
ring finger protein 168, E3 ubiquitin protein ligase
|
|
RNF17
|
ring finger protein 17
|
|
RNF2
|
ring finger protein 2
|
|
RNF31
|
ring finger protein 31
|
|
RNF5
|
ring finger protein 5, E3 ubiquitin protein ligase
|
|
RNF8
|
ring finger protein 8, E3 ubiquitin protein ligase
|
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
ROPN1L
|
rhophilin associated tail protein 1-like
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RORA
|
RAR-related orphan receptor A
|
|
RORC
|
RAR-related orphan receptor C
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPL19
|
ribosomal protein L19
|
|
RPL39
|
ribosomal protein L39
|
|
RPL41
|
ribosomal protein L41
|
|
RPL7A
|
ribosomal protein L7a
|
|
RPLP0
|
ribosomal protein, large, P0
|
|
RPN2
|
ribophorin II
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KA6
|
ribosomal protein S6 kinase, 90kDa, polypeptide 6
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
|
RQCD1
|
RCD1 required for cell differentiation1 homolog (S. pombe)
|
|
RRAD
|
Ras-related associated with diabetes
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RRP1B
|
ribosomal RNA processing 1B
|
|
RSF1
|
remodeling and spacing factor 1
|
|
RSPO1
|
R-spondin 1
|
|
RUNDC3B
|
RUN domain containing 3B
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RXRB
|
retinoid X receptor, beta
|
|
S100A11
|
S100 calcium binding protein A11
|
|
S100A14
|
S100 calcium binding protein A14
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A6
|
S100 calcium binding protein A6
|
|
S100A7
|
S100 calcium binding protein A7
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
S100P
|
S100 calcium binding protein P
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
S1PR4
|
sphingosine-1-phosphate receptor 4
|
|
SAA1
|
serum amyloid A1
|
|
SACK1D
|
scaffolding CK1 anchoring protein D
|
|
SAE1
|
SUMO1 activating enzyme subunit 1
|
|
SAFB
|
scaffold attachment factor B
|
|
SAFB2
|
scaffold attachment factor B2
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SASH1
|
SAM and SH3 domain containing 1
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SAT2
|
spermidine/spermine N1-acetyltransferase family member 2
|
|
SATB1
|
SATB homeobox 1
|
|
SAV1
|
salvador family WW domain containing protein 1
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCGB1D2
|
secretoglobin, family 1D, member 2
|
|
SCGB2A1
|
secretoglobin, family 2A, member 1
|
|
SCGB2A2
|
secretoglobin, family 2A, member 2
|
|
SCGB3A1
|
secretoglobin, family 3A, member 1
|
|
SCN1B
|
sodium channel, voltage gated, type I beta subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCO2
|
SCO2 cytochrome c oxidase assembly protein
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SCUBE2
|
signal peptide, CUB domain, EGF-like 2
|
|
SDC1
|
syndecan 1
|
|
SDC2
|
syndecan 2
|
|
SDC4
|
syndecan 4
|
|
SDCBP
|
syndecan binding protein (syntenin)
|
|
SDPR
|
serum deprivation response
|
|
SEC14L2
|
SEC14-like 2 (S. cerevisiae)
|
|
SEL1L
|
sel-1 suppressor of lin-12-like (C. elegans)
|
|
SELE
|
selectin E
|
|
SELENBP1
|
selenium binding protein 1
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA3C
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SEMA4F
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F
|
|
SEMA6B
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B
|
|
SENP5
|
SUMO1/sentrin specific peptidase 5
|
|
SEPP1
|
selenoprotein P, plasma, 1
|
|
SEPT9
|
septin 9
|
|
SERBP1
|
SERPINE1 mRNA binding protein 1
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA10
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10
|
|
SERPINA4
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPINH1
|
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
|
|
SERTAD1
|
SERTA domain containing 1
|
|
SESN2
|
sestrin 2
|
|
SET
|
SET nuclear proto-oncogene
|
|
SETD2
|
SET domain containing 2
|
|
SETD8
|
SET domain containing (lysine methyltransferase) 8
|
|
SFN
|
stratifin
|
|
SFR1
|
SWI5-dependent recombination repair 1
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFRP5
|
secreted frizzled-related protein 5
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SGK3
|
serum/glucocorticoid regulated kinase family, member 3
|
|
SH2D3A
|
SH2 domain containing 3A
|
|
SH2D3C
|
SH2 domain containing 3C
|
|
SH3GL2
|
SH3-domain GRB2-like 2
|
|
SH3GLB1
|
SH3-domain GRB2-like endophilin B1
|
|
SH3KBP1
|
SH3-domain kinase binding protein 1
|
|
SH3PXD2A
|
SH3 and PX domains 2A
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHFM1
|
split hand/foot malformation (ectrodactyly) type 1
|
|
SHH
|
sonic hedgehog
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SHOX2
|
short stature homeobox 2
|
|
SIAH1
|
siah E3 ubiquitin protein ligase 1
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIM2
|
single-minded family bHLH transcription factor 2
|
|
SIN3A
|
SIN3 transcription regulator family member A
|
|
SIN3B
|
SIN3 transcription regulator family member B
|
|
SIPA1
|
signal-induced proliferation-associated 1
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SIRT3
|
sirtuin 3
|
|
SIRT6
|
sirtuin 6
|
|
SIRT7
|
sirtuin 7
|
|
SIVA1
|
SIVA1, apoptosis-inducing factor
|
|
SIX1
|
SIX homeobox 1
|
|
SKI
|
SKI proto-oncogene
|
|
SKIL
|
SKI-like proto-oncogene
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6
|
|
SLC12A7
|
solute carrier family 12 (potassium/chloride transporter), member 7
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC16A7
|
solute carrier family 16 (monocarboxylate transporter), member 7
|
|
SLC19A2
|
solute carrier family 19 (thiamine transporter), member 2
|
|
SLC19A3
|
solute carrier family 19 (thiamine transporter), member 3
|
|
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5
|
|
SLC22A16
|
solute carrier family 22 (organic cation/carnitine transporter), member 16
|
|
SLC22A18
|
solute carrier family 22, member 18
|
|
SLC25A19
|
solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19
|
|
SLC25A27
|
solute carrier family 25, member 27
|
|
SLC25A43
|
solute carrier family 25, member 43
|
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5
|
|
SLC26A1
|
solute carrier family 26 (anion exchanger), member 1
|
|
SLC28A1
|
solute carrier family 28 (concentrative nucleoside transporter), member 1
|
|
SLC28A3
|
solute carrier family 28 (concentrative nucleoside transporter), member 3
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC30A1
|
solute carrier family 30 (zinc transporter), member 1
|
|
SLC30A4
|
solute carrier family 30 (zinc transporter), member 4
|
|
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 2
|
|
SLC38A1
|
solute carrier family 38, member 1
|
|
SLC39A1
|
solute carrier family 39 (zinc transporter), member 1
|
|
SLC39A10
|
solute carrier family 39 (zinc transporter), member 10
|
|
SLC39A2
|
solute carrier family 39 (zinc transporter), member 2
|
|
SLC39A6
|
solute carrier family 39 (zinc transporter), member 6
|
|
SLC39A9
|
solute carrier family 39, member 9
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC4A7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC5A6
|
solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLCO1A2
|
solute carrier organic anion transporter family, member 1A2
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLCO2B1
|
solute carrier organic anion transporter family, member 2B1
|
|
SLCO3A1
|
solute carrier organic anion transporter family, member 3A1
|
|
SLCO5A1
|
solute carrier organic anion transporter family, member 5A1
|
|
SLIT1
|
slit homolog 1 (Drosophila)
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SLIT3
|
slit homolog 3 (Drosophila)
|
|
SLX4
|
SLX4 structure-specific endonuclease subunit
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCE1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMOX
|
spermine oxidase
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SMUG1
|
single-strand-selective monofunctional uracil-DNA glycosylase 1
|
|
SMURF1
|
SMAD specific E3 ubiquitin protein ligase 1
|
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2
|
|
SMYD3
|
SET and MYND domain containing 3
|
|
SMYD4
|
SET and MYND domain containing 4
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI1P1
|
snail family zinc finger 1 pseudogene 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SND1
|
staphylococcal nuclease and tudor domain containing 1
|
|
SNORD50A
|
small nucleolar RNA, C/D box 50A
|
|
SNRPD1
|
small nuclear ribonucleoprotein D1 polypeptide 16kDa
|
|
SNRPE
|
small nuclear ribonucleoprotein polypeptide E
|
|
SNTA1
|
syntrophin, alpha 1
|
|
SNW1
|
SNW domain containing 1
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOCS4
|
suppressor of cytokine signaling 4
|
|
SOCS7
|
suppressor of cytokine signaling 7
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SORT1
|
sortilin 1
|
|
SOST
|
sclerostin
|
|
SOSTDC1
|
sclerostin domain containing 1
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX17
|
SRY (sex determining region Y)-box 17
|
|
SOX18
|
SRY (sex determining region Y)-box 18
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
SOX7
|
SRY (sex determining region Y)-box 7
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPAG9
|
sperm associated antigen 9
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPDEF
|
SAM pointed domain containing ETS transcription factor
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SPOP
|
speckle-type POZ protein
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPSB1
|
splA/ryanodine receptor domain and SOCS box containing 1
|
|
SQLE
|
squalene epoxidase
|
|
SQSTM1
|
sequestosome 1
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRCIN1
|
SRC kinase signaling inhibitor 1
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SRPK1
|
SRSF protein kinase 1
|
|
SRSF6
|
serine/arginine-rich splicing factor 6
|
|
SRXN1
|
sulfiredoxin 1
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST18
|
suppression of tumorigenicity 18, zinc finger
|
|
ST2
|
suppression of tumorigenicity 2
|
|
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
|
|
ST6GALNAC1
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1
|
|
ST6GALNAC2
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
|
|
ST7
|
suppression of tumorigenicity 7
|
|
ST8SIA1
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
|
|
STAB1
|
stabilin 1
|
|
STAP2
|
signal transducing adaptor family member 2
|
|
STARD10
|
StAR-related lipid transfer (START) domain containing 10
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STC1
|
stanniocalcin 1
|
|
STC2
|
stanniocalcin 2
|
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STK17B
|
serine/threonine kinase 17b
|
|
STK3
|
serine/threonine kinase 3
|
|
STMN1
|
stathmin 1
|
|
STOML2
|
stomatin (EPB72)-like 2
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
STX18
|
syntaxin 18
|
|
STXBP4
|
syntaxin binding protein 4
|
|
STYK1
|
serine/threonine/tyrosine kinase 1
|
|
SULF1
|
sulfatase 1
|
|
SULF2
|
sulfatase 2
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SULT1A2
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
SULT2B1
|
sulfotransferase family, cytosolic, 2B, member 1
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUSD2
|
sushi domain containing 2
|
|
SUV420H2
|
suppressor of variegation 4-20 homolog 2 (Drosophila)
|
|
SV2A
|
synaptic vesicle glycoprotein 2A
|
|
SYK
|
spleen tyrosine kinase
|
|
SYNJ2BP
|
synaptojanin 2 binding protein
|
|
SYNM
|
synemin, intermediate filament protein
|
|
SYT5
|
synaptotagmin V
|
|
SYTL2
|
synaptotagmin-like 2
|
|
T
|
T, brachyury homolog (mouse)
|
|
TAB1
|
TGF-beta activated kinase 1/MAP3K7 binding protein 1
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACC1
|
transforming, acidic coiled-coil containing protein 1
|
|
TACC2
|
transforming, acidic coiled-coil containing protein 2
|
|
TACR1
|
tachykinin receptor 1
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TADA3
|
transcriptional adaptor 3
|
|
TAGLN
|
transgelin
|
|
TANC2
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2
|
|
TANK
|
TRAF family member-associated NFKB activator
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TARBP2
|
TAR (HIV-1) RNA binding protein 2
|
|
TARP
|
TCR gamma alternate reading frame protein
|
|
TAX1BP3
|
Tax1 (human T-cell leukemia virus type I) binding protein 3
|
|
TAZ
|
tafazzin
|
|
TBC1D4
|
TBC1 domain family, member 4
|
|
TBCC
|
tubulin folding cofactor C
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBP
|
TATA box binding protein
|
|
TBX2
|
T-box 2
|
|
TBX3
|
T-box 3
|
|
TCF3
|
transcription factor 3
|
|
TCF4
|
transcription factor 4
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCIRG1
|
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TCL1B
|
T-cell leukemia/lymphoma 1B
|
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERF2IP
|
telomeric repeat binding factor 2, interacting protein
|
|
TERT
|
telomerase reverse transcriptase
|
|
TES
|
testin LIM domain protein
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
|
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
|
TFAP4
|
transcription factor AP-4 (activating enhancer binding protein 4)
|
|
TFDP1
|
transcription factor Dp-1
|
|
TFF1
|
trefoil factor 1
|
|
TFF2
|
trefoil factor 2
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TFRC
|
transferrin receptor
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TGM2
|
transglutaminase 2
|
|
TGM3
|
transglutaminase 3
|
|
THBS1
|
thrombospondin 1
|
|
THBS4
|
thrombospondin 4
|
|
THEMIS2
|
thymocyte selection associated family member 2
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIAL1
|
TIA1 cytotoxic granule-associated RNA binding protein-like 1
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TIGAR
|
TP53 induced glycolysis regulatory phosphatase
|
|
TIMELESS
|
timeless circadian clock
|
|
TIMM17A
|
translocase of inner mitochondrial membrane 17 homolog A (yeast)
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TIMP4
|
TIMP metallopeptidase inhibitor 4
|
|
TJP1
|
tight junction protein 1
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TKTL1
|
transketolase-like 1
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
|
TLK1
|
tousled-like kinase 1
|
|
TLN1
|
talin 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM158
|
transmembrane protein 158 (gene/pseudogene)
|
|
TMEM25
|
transmembrane protein 25
|
|
TMEM8B
|
transmembrane protein 8B
|
|
TMPRSS4
|
transmembrane protease, serine 4
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
|
TMSB15A
|
thymosin beta 15a
|
|
TMSB4X
|
thymosin beta 4, X-linked
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial)
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF10C
|
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF18
|
tumor necrosis factor (ligand) superfamily, member 18
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNN
|
tenascin N
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNS4
|
tensin 4
|
|
TOB1
|
transducer of ERBB2, 1
|
|
TOMM34
|
translocase of outer mitochondrial membrane 34
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOP3A
|
topoisomerase (DNA) III alpha
|
|
TOP3B
|
topoisomerase (DNA) III beta
|
|
TOPBP1
|
topoisomerase (DNA) II binding protein 1
|
|
TOX3
|
TOX high mobility group box family member 3
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP53INP1
|
tumor protein p53 inducible nuclear protein 1
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPD52
|
tumor protein D52
|
|
TPK1
|
thiamin pyrophosphokinase 1
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TPM4
|
tropomyosin 4
|
|
TPO
|
thyroid peroxidase
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TPSG1
|
tryptase gamma 1
|
|
TRADD
|
TNFRSF1A-associated via death domain
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF4
|
TNF receptor-associated factor 4
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRAF7
|
TNF receptor-associated factor 7, E3 ubiquitin protein ligase
|
|
TRAP1
|
TNF receptor-associated protein 1
|
|
TRD
|
T cell receptor delta locus
|
|
TRERF1
|
transcriptional regulating factor 1
|
|
TRG
|
T cell receptor gamma locus
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRIM22
|
tripartite motif containing 22
|
|
TRIM24
|
tripartite motif containing 24
|
|
TRIM25
|
tripartite motif containing 25
|
|
TRIM27
|
tripartite motif containing 27
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRIM29
|
tripartite motif containing 29
|
|
TRIM37
|
tripartite motif containing 37
|
|
TRIM62
|
tripartite motif containing 62
|
|
TRIP10
|
thyroid hormone receptor interactor 10
|
|
TRMT12
|
tRNA methyltransferase 12 homolog (S. cerevisiae)
|
|
TRMT2A
|
tRNA methyltransferase 2 homolog A (S. cerevisiae)
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSG101
|
tumor susceptibility 101
|
|
TSHZ2
|
teashirt zinc finger homeobox 2
|
|
TSHZ3
|
teashirt zinc finger homeobox 3
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSPAN1
|
tetraspanin 1
|
|
TSPAN13
|
tetraspanin 13
|
|
TSPO
|
translocator protein (18kDa)
|
|
TSSC1
|
tumor suppressing subtransferable candidate 1
|
|
TTK
|
TTK protein kinase
|
|
TUBA1B
|
tubulin, alpha 1b
|
|
TUBA4A
|
tubulin, alpha 4a
|
|
TUBB
|
tubulin, beta class I
|
|
TUBB1
|
tubulin, beta 1 class VI
|
|
TUBB2B
|
tubulin, beta 2B class IIb
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUBB4B
|
tubulin, beta 4B class IVb
|
|
TUBG1
|
tubulin, gamma 1
|
|
TUSC5
|
tumor suppressor candidate 5
|
|
TWF1
|
twinfilin actin binding protein 1
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
TXN
|
thioredoxin
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TXNRD1
|
thioredoxin reductase 1
|
|
TYK2
|
tyrosine kinase 2
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
TYRO3
|
TYRO3 protein tyrosine kinase
|
|
UBA2
|
ubiquitin-like modifier activating enzyme 2
|
|
UBASH3B
|
ubiquitin associated and SH3 domain containing B
|
|
UBE2B
|
ubiquitin-conjugating enzyme E2B
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UBE2N
|
ubiquitin-conjugating enzyme E2N
|
|
UBE2Q1
|
ubiquitin-conjugating enzyme E2Q family member 1
|
|
UBE2Q2
|
ubiquitin-conjugating enzyme E2Q family member 2
|
|
UBE2T
|
ubiquitin-conjugating enzyme E2T
|
|
UBE2V2
|
ubiquitin-conjugating enzyme E2 variant 2
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UBE4B
|
ubiquitination factor E4B
|
|
UBQLN1
|
ubiquilin 1
|
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5
|
|
UCA1
|
urothelial cancer associated 1 (non-protein coding)
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UGCG
|
UDP-glucose ceramide glucosyltransferase
|
|
UGT1A
|
UDP glucuronosyltransferase 1 family, polypeptide A complex locus
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
|
UGT1A8
|
UDP glucuronosyltransferase 1 family, polypeptide A8
|
|
UGT2B11
|
UDP glucuronosyltransferase 2 family, polypeptide B11
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
UGT2B28
|
UDP glucuronosyltransferase 2 family, polypeptide B28
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
UGT8
|
UDP glycosyltransferase 8
|
|
UHRF1
|
ubiquitin-like with PHD and ring finger domains 1
|
|
UIMC1
|
ubiquitin interaction motif containing 1
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
UMPS
|
uridine monophosphate synthetase
|
|
UPK2
|
uroplakin 2
|
|
UPP1
|
uridine phosphorylase 1
|
|
UQCRC1
|
ubiquinol-cytochrome c reductase core protein I
|
|
UQCRFS1
|
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
|
|
USP11
|
ubiquitin specific peptidase 11
|
|
USP22
|
ubiquitin specific peptidase 22
|
|
USP28
|
ubiquitin specific peptidase 28
|
|
USP32
|
ubiquitin specific peptidase 32
|
|
USP39
|
ubiquitin specific peptidase 39
|
|
USP9X
|
ubiquitin specific peptidase 9, X-linked
|
|
USPL1
|
ubiquitin specific peptidase like 1
|
|
UTP20
|
UTP20, small subunit (SSU) processome component, homolog (yeast)
|
|
UTRN
|
utrophin
|
|
UTS2
|
urotensin 2
|
|
VANGL1
|
VANGL planar cell polarity protein 1
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VARS2
|
valyl-tRNA synthetase 2, mitochondrial
|
|
VASH1
|
vasohibin 1
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VAV2
|
vav 2 guanine nucleotide exchange factor
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCAN
|
versican
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VGLL1
|
vestigial-like family member 1
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VIP
|
vasoactive intestinal peptide
|
|
VIPR1
|
vasoactive intestinal peptide receptor 1
|
|
VIPR2
|
vasoactive intestinal peptide receptor 2
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
VMP1
|
vacuole membrane protein 1
|
|
VPS4B
|
vacuolar protein sorting 4 homolog B (S. cerevisiae)
|
|
VRK1
|
vaccinia related kinase 1
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
VTN
|
vitronectin
|
|
VWA5A
|
von Willebrand factor A domain containing 5A
|
|
VWF
|
von Willebrand factor
|
|
WASF2
|
WAS protein family, member 2
|
|
WASF3
|
WAS protein family, member 3
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
WDR5
|
WD repeat domain 5
|
|
WDR77
|
WD repeat domain 77
|
|
WDR92
|
WD repeat domain 92
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WHSC1L1
|
Wolf-Hirschhorn syndrome candidate 1-like 1
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WIPF1
|
WAS/WASL interacting protein family, member 1
|
|
WISP1
|
WNT1 inducible signaling pathway protein 1
|
|
WISP2
|
WNT1 inducible signaling pathway protein 2
|
|
WISP3
|
WNT1 inducible signaling pathway protein 3
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT10B
|
wingless-type MMTV integration site family, member 10B
|
|
WNT11
|
wingless-type MMTV integration site family, member 11
|
|
WNT2
|
wingless-type MMTV integration site family member 2
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT5B
|
wingless-type MMTV integration site family, member 5B
|
|
WNT9A
|
wingless-type MMTV integration site family, member 9A
|
|
WRAP53
|
WD repeat containing, antisense to TP53
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWC1
|
WW and C2 domain containing 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
WWP1
|
WW domain containing E3 ubiquitin protein ligase 1
|
|
WWP2
|
WW domain containing E3 ubiquitin protein ligase 2
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
XBP1
|
X-box binding protein 1
|
|
XDH
|
xanthine dehydrogenase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XIST
|
X inactive specific transcript (non-protein coding)
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XPO1
|
exportin 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC2
|
X-ray repair complementing defective repair in Chinese hamster cells 2
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
YWHAG
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
YY1
|
YY1 transcription factor
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZBP1
|
Z-DNA binding protein 1
|
|
ZBTB12
|
zinc finger and BTB domain containing 12
|
|
ZBTB33
|
zinc finger and BTB domain containing 33
|
|
ZBTB35
|
zinc finger and BTB domain containing 35
|
|
ZBTB4
|
zinc finger and BTB domain containing 4
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZFAS1
|
ZNFX1 antisense RNA 1
|
|
ZFHX3
|
zinc finger homeobox 3
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZMIZ1
|
zinc finger, MIZ-type containing 1
|
|
ZNF217
|
zinc finger protein 217
|
|
ZNF281
|
zinc finger protein 281
|
|
ZNF282
|
zinc finger protein 282
|
|
ZNF350
|
zinc finger protein 350
|
|
ZNF365
|
zinc finger protein 365
|
|
ZNF366
|
zinc finger protein 366
|
|
ZNF577
|
zinc finger protein 577
|
|
ZNF668
|
zinc finger protein 668
|
|
ZNF703
|
zinc finger protein 703
|
